247 related articles for article (PubMed ID: 3555030)
21. Randomized trial of ciprofloxacin compared with other antimicrobial therapy in the treatment of osteomyelitis.
Greenberg RN; Tice AD; Marsh PK; Craven PC; Reilly PM; Bollinger M; Weinandt WJ
Am J Med; 1987 Apr; 82(4A):266-9. PubMed ID: 3555046
[TBL] [Abstract][Full Text] [Related]
22. Use of intravenous ciprofloxacin in difficult-to-treat infections.
Giamarellou H; Galanakis N
Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
[TBL] [Abstract][Full Text] [Related]
23. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
Gilbert DN; Tice AD; Marsh PK; Craven PC; Preheim LC
Am J Med; 1987 Apr; 82(4A):254-8. PubMed ID: 3555044
[TBL] [Abstract][Full Text] [Related]
24. Comparison of oral erythromycin ethylsuccinate and ciprofloxacin in the treatment of acute respiratory tract infections.
Feld MS; Carnegie C; Macklin J; Coles S
Br J Clin Pract; 1990 Oct; 44(10):404-8. PubMed ID: 2268518
[TBL] [Abstract][Full Text] [Related]
25. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
Daikos GL; Kathpalia SB; Sharifi R; Lolans VT; Jackson GG
Am J Med; 1987 Apr; 82(4A):290-4. PubMed ID: 3555050
[TBL] [Abstract][Full Text] [Related]
26. Oral ciprofloxacin for treatment of chronic osteomyelitis.
Yamaguti A; Trevisanello C; Lobo IM; Carvalho MC; Bortoletto ML; Silva ML; Brasil Filho R; Levi GC; Mendonça JS
Int J Clin Pharmacol Res; 1993; 13(2):75-9. PubMed ID: 8354592
[TBL] [Abstract][Full Text] [Related]
27. Treatment of urinary tract infection by Gardnerella vaginalis: a comparison of oral metronidazole versus ampicillin.
Pedraza-Avilés AG; Zaragoza MC; Mota-Vázquez R; Hernández-Soto C; Ramírez-Santana M; Terrazas-Maldonado ML
Rev Latinoam Microbiol; 2001; 43(2):65-9. PubMed ID: 17061489
[TBL] [Abstract][Full Text] [Related]
28. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
30. Clinical experience with ciprofloxacin: analysis of a multicenter study.
Karimi K
Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
[TBL] [Abstract][Full Text] [Related]
31. Oral ciprofloxacin treatment of infections in geriatric patients.
Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
[TBL] [Abstract][Full Text] [Related]
32. Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.
Louie TJ
CMAJ; 1994 Mar; 150(5):669-76. PubMed ID: 8313286
[TBL] [Abstract][Full Text] [Related]
33. Treatment of respiratory tract infections with ciprofloxacin.
Raoof S; Wollschlager C; Khan F
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():139-45. PubMed ID: 3804902
[TBL] [Abstract][Full Text] [Related]
34. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.
Iravani A; Klimberg I; Briefer C; Munera C; Kowalsky SF; Echols RM
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():67-75. PubMed ID: 10225575
[TBL] [Abstract][Full Text] [Related]
35. [The efficacy and tolerance of Bay-o-9867 (ciprofloxacin) in the treatment of infections of the urinary tract and of the lower respiratory tract].
Quartieri F; Bolognesi S; Sconosciuto F
Recenti Prog Med; 1994 Feb; 85(2):96-100. PubMed ID: 8184195
[TBL] [Abstract][Full Text] [Related]
36. Oral ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
Lesse AJ; Freer C; Salata RA; Francis JB; Scheld WM
Am J Med; 1987 Apr; 82(4A):247-53. PubMed ID: 3555043
[TBL] [Abstract][Full Text] [Related]
37. Oral ciprofloxacin for treatment of severe infections.
Lobo IM; Silva NF; Assef MC; Mangini C; Silva ML; Bortoletto ML; Mendonça JS; Levi GC
Int J Clin Pharmacol Res; 1993; 13(2):81-5. PubMed ID: 8354593
[TBL] [Abstract][Full Text] [Related]
38. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Lorian V; Pavletich K
Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
[TBL] [Abstract][Full Text] [Related]
39. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.
Caldwell JW; Singh S; Johnson RH
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583
[TBL] [Abstract][Full Text] [Related]
40. Once-daily fleroxacin versus twice-daily ciprofloxacin in the treatment of complicated urinary tract infections.
Frankenschmidt A; Naber KG; Bischoff W; Kullmann K
J Urol; 1997 Oct; 158(4):1494-9. PubMed ID: 9302150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
